Sign In
Buy CRL
$179.87
+5.08 (+2.91%)
At Close: Jun 03, 2026
Charles River (CRL) Introduces LVV Packaging Plasmids
09:56am, Wednesday, 14'th Jun 2023
Charles River (CRL) launches packaging plasmids to accelerate and standardize lentiviral vector development.
Charles River (CRL) Inks a CDMO Partnership for Bladder Cancer
10:47am, Tuesday, 13'th Jun 2023
Curigin's oncolytic RNAi gene therapies are set to leverage Charles River's (CRL) expertise in CDMO solutions.
Charles River (CRL) to Aid INADcure in Plasmid DNA Manufacture
09:57am, Friday, 09'th Jun 2023
Charles River (CRL) collaborates with INADcure Foundation on plasmid DNA manufacturing for developing treatments for INAD patients.
Charles River (CRL) to Build RightSource Lab With New Pact
12:20pm, Thursday, 01'st Jun 2023
Charles River (CRL) will establish a CGMP testing lab at Wheeler's factory through latest partnership.
Here's Why You Should Retain Charles River (CRL) Stock Now
12:02pm, Wednesday, 17'th May 2023
Charles River's (CRL) share price is likely to grow, backed by strategic acquisitions and the DSA segment's strength.
3 DNA Stocks to Buy for the Synthetic Biology Revolution
04:05pm, Sunday, 14'th May 2023
Biology is the study of life. And synthetic biology is the creation of new life for new purposes.
Charles River: Strong Earnings Manifest Life Science Megatrends
11:09pm, Thursday, 11'th May 2023
In the past year, Charles River (-13.59%) has trailed both the S&P 500 (+4.83%) in addition to the healthcare index, IXHC (+21.81%). This reflects a -44.57% YoY free cash flow decline owing to materia
Charles River (CRL) Q1 Earnings Top Estimates, View Narrowed
12:57pm, Thursday, 11'th May 2023
Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.
Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
09:56am, Thursday, 11'th May 2023
Charles River Laboratories (CRL) came out with quarterly earnings of $2.78 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.75 per share a year ago.
Charles River (CRL) to Report Q1 Earnings: What's in Store?
12:57pm, Monday, 01'st May 2023
Continued global demand for research models and associated services are likely to have driven Charles River's (CRL) Q1 revenues.
3 Healthcare Stocks With Huge Growth Potential
06:21pm, Monday, 24'th Apr 2023
It's been a rocky market for growth stocks over the past 18 months. We've seen a flurry of layoffs and spending cutbacks from leading tech companies.
Charles River Associates (CRA) to Host First-Quarter Fiscal 2023 Financial Results Conference Call on May 4
08:30am, Thursday, 20'th Apr 2023
BOSTON--(BUSINESS WIRE)--CRAI Q1'23 Earnings Advisory
Confounded's Complete All-Weather Portfolio Revealed
05:17am, Saturday, 01'st Apr 2023
Most readers follow my work for the extensive writing I have done referencing my aggressive growth portfolio. However, the vast majority of my net worth is held in my all-weather portfolio. In this ar
Why Is Charles River (CRL) Down 14.8% Since Last Earnings Report?
12:59pm, Friday, 24'th Mar 2023
Charles River (CRL) reported earnings 30 days ago. What's next for the stock?
Charles River's (CRL) New Cloud Platform Offers Real-Time Data
04:47pm, Wednesday, 15'th Mar 2023
Charles River (CRL) launches cloud-based platform Apollo which enhances decision making abilities by providing real-time Toxicology study data.
